Previous 10 | Next 10 |
home / stock / rhhby / rhhby news
It may seem counter-intuitive that during a year in which the world economy recorded its weakest performance since the global financial crisis, asset prices delivered fantastic returns across the board. Somewhat ironically, today’s situation is the exact opposite of the one we desc...
Looking for a pharmaceutical industry overview? Let’s start with the world’s biggest pharmaceutical markets, the US and Europe. All of the biggest pharma companies on Pharmaceutical Technology’s list of the 10 top pharmaceutical companies by market share are ...
Deals and Financings I-Mab (IMAB), a Shanghai biotech, raised $104 million in its IPO on the NASDAQ exchange to support its portfolio of more than ten biologic products (see story ). I-Mab was founded in 2016 by C-Bridge Capital and Tasly Pharma, which merged two China companies, Third Vent...
Today, we will study why Adverum Biotechnologies ( ADVM ) is a promising gene player in 2020. Company overview Adverum Biotechnologies is a clinical-stage gene therapy company focused on ocular and rare diseases. The company is evaluating its lead asset, ADVM-022 in wet AMD (age-related ...
Investing in biotech stocks can seem like a speculative gamble on binary outcomes, sort of like buying lottery tickets. Fortunately, there are some mid-cap biotechs actually making a profit and that have development pipelines stocked with drug candidates that could produce big winners, giving pa...
This article was originally published on December 17th, 2019. Most U.S. investors don't hold nearly enough exposure to international securities. This is where a fund like Voya Global Advantage and Premium Opportunity Fund ( IGA ) can come in to increase such exposure. Even better, the fund...
Sarepta Therapeutics, Inc. ( SRPT ) should get the ball rolling in 2020 as it has now submitted a rolling New Drug Application (NDA) in January for its clinical candidate casimersen with a potential FDA action date somewhere around mid to late 2020. This could help build an upward trending sto...
January 15, 2020 FN Media Group Presents USA News Group Commentary Los Angeles, CA – January 15, 2020 – USA News Group – With a new decade still less than a month underway, it appears the 2020s should see some major breakthroughs in the fight against ...
- Immunocompromised transplant recipients are at risk of major complications when infected with adenovirus, a common and highly contagious virus - Healthcare professionals can use this new test to determine whether transplant patients are at risk of developing severe illness f...
Top DNA sequencing company Illumina (NASDAQ: ILMN) has signed a pact with global pharmaceutical giant Roche (OTC: RHHBY) in the field of oncology, the Illumina's CEO Francis deSouza announced. On Monday, deSouza shared the news at the high-profile annual J.P. Morgan Healthcare Conferen...
News, Short Squeeze, Breakout and More Instantly...
Roche Holding Ltd ADR Company Name:
RHHBY Stock Symbol:
OTCMKTS Market:
Wednesday, HOOKIPA Pharma Inc (NASDAQ:HOOK) received clearance from the FDA for its Investigational New Drug (IND) application for H...
– Results from the Phase III study showed that subcutaneous (SC) injection was consistent with IV infusion and demonstrated near-complete suppression of relapse activity (97%) and MRI lesions (97.2%) through 48 weeks – – The twice-yearly, 10-minute SC injection has th...
Monday, Roche Holdings AG (OTC:RHHBY) announced topline data from Phase 3 STARGLO study of Columvi (glofitamab) in combination ...